Nao Shimizu

464 citations
15 papers · 297 indexed · h-index 6
Topics
Pluripotent Stem Cells Research (4 papers)Melanoma and MAPK Pathways (3 papers)Risk and Safety Analysis (2 papers)
Partner nations
JapanCanadaUnited States

In The Last Decade

Nao Shimizu

12 papers receiving 294 citations

Peers

Nao Shimizu
Comparison fields: 5 of 79
  • Molecular Biology 205
  • Oncology 46
  • Cell Biology 40
  • Cancer Research 31
  • Immunology 30
Replace Kouhei Masuda with:
Kouhei Masuda Japan
Giuseppa Chirico Italy
Elena Gómez‐Casero Spain
Juan Carlos Higareda‐Almaraz Germany
Dimitri Lodygin Germany
Ines Köhler Sweden
Ryuichi Nishigaki Japan
Nicholas Blazanin United States
Müge Öğrünç United States
Nao Shimizu relative to Kouhei Masuda Japan Kouhei Masuda's profile →
Citations per field
00.5×1.5×
Kouhei Masuda · 1×
Citations per year

Countries citing papers authored by Nao Shimizu

Since Specialization
Citations

This map shows the geographic impact of Nao Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nao Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nao Shimizu more than expected).

Fields of papers citing papers by Nao Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nao Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nao Shimizu. The network helps show where Nao Shimizu may publish in the future.

Co-authorship network of co-authors of Nao Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Nao Shimizu. A scholar is included among the top collaborators of Nao Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nao Shimizu. Nao Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 4
3 0
4 2
5
Sulfur isotopic variations during subduction of hydrated lithosphere: the Erro Tobbio case
2
6 38
7 24
8 0
9 0
10 21
11 1
12 2
13 21
14 58
15 123

About Nao Shimizu

Nao Shimizu is a scholar working on Toxicology, Statistics, Probability and Uncertainty and Safety, Risk, Reliability and Quality, having authored 15 papers that have together received 297 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (4 papers), Melanoma and MAPK Pathways (3 papers) and Risk and Safety Analysis (2 papers). The work is most often cited by research in Aging (11 citations), Molecular Biology (205 citations) and Cell Biology (40 citations). Nao Shimizu has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Hiroshi Nishina, Toshiaki Katada, Jungwon Seo, Shinya Ohata, Daiju Kitagawa, Kentaro Nakagawa, Gen Nishitai, Tomomi Watanabe‐Asaka, Hiroyuki Kishimoto and Teiji Wada. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Organic Chemistry and Journal of Cellular Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026